| Symbol |
Name |
Standardized Value |
|
TP53
|
tumor protein p53
|
2.953
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
2.812
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
2.716
|
|
PTEN
|
phosphatase and tensin homolog
|
2.639
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
2.625
|
|
KRT7
|
keratin 7, type II
|
2.607
|
|
MME
|
membrane metallo-endopeptidase
|
2.571
|
|
PAX8
|
paired box 8
|
2.555
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
2.552
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
2.545
|
|
PGR
|
progesterone receptor
|
2.514
|
|
ESR1
|
estrogen receptor 1
|
2.485
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
2.451
|
|
BRCA1
|
breast cancer 1, early onset
|
2.448
|
|
MYOG
|
myogenin (myogenic factor 4)
|
2.44
|
|
CALD1
|
caldesmon 1
|
2.435
|
|
MSH6
|
mutS homolog 6
|
2.42
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
2.42
|
|
MLH1
|
mutL homolog 1
|
2.411
|
|
WT1
|
Wilms tumor 1
|
2.404
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
2.402
|
|
CALB2
|
calbindin 2
|
2.331
|
|
KRT5
|
keratin 5, type II
|
2.329
|
|
BRCA2
|
breast cancer 2, early onset
|
2.325
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
2.316
|
|
CD99
|
CD99 molecule
|
2.312
|
|
MSH2
|
mutS homolog 2
|
2.295
|
|
CD99L2
|
CD99 molecule-like 2
|
2.289
|
|
KRT20
|
keratin 20, type I
|
2.276
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
2.267
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
2.263
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
2.237
|
|
EGFR
|
epidermal growth factor receptor
|
2.231
|
|
SYP
|
synaptophysin
|
2.202
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
2.195
|
|
CD274
|
CD274 molecule
|
2.179
|
|
CD34
|
CD34 molecule
|
2.171
|
|
JAZF1
|
JAZF zinc finger 1
|
2.169
|
|
NAPSA
|
napsin A aspartic peptidase
|
2.142
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
2.118
|
|
KRT8
|
keratin 8, type II
|
2.07
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
2.06
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
2.058
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
2.055
|
|
MYOD1
|
myogenic differentiation 1
|
2.026
|
|
NCAM1
|
neural cell adhesion molecule 1
|
2.002
|
|
DICER1
|
dicer 1, ribonuclease type III
|
2.0
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
1.984
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.973
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
1.967
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
1.965
|
|
NKX2-1
|
NK2 homeobox 1
|
1.959
|
|
CCNE1
|
cyclin E1
|
1.958
|
|
GATA3
|
GATA binding protein 3
|
1.954
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.95
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
1.949
|
|
CDX2
|
caudal type homeobox 2
|
1.946
|
|
ARID1B
|
AT rich interactive domain 1B (SWI1-like)
|
1.939
|
|
ZC3H7B
|
zinc finger CCCH-type containing 7B
|
1.93
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
1.922
|
|
NUTM2A
|
NUT family member 2A
|
1.922
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
1.919
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
1.916
|
|
MB
|
myoglobin
|
1.905
|
|
AFP
|
alpha-fetoprotein
|
1.9
|
|
CCND1
|
cyclin D1
|
1.9
|
|
EPCAM
|
epithelial cell adhesion molecule
|
1.9
|
|
CDK4
|
cyclin-dependent kinase 4
|
1.899
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.882
|
|
SALL4
|
spalt-like transcription factor 4
|
1.878
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.849
|
|
HMGA2
|
high mobility group AT-hook 2
|
1.846
|
|
L1CAM
|
L1 cell adhesion molecule
|
1.834
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.828
|
|
KRT19
|
keratin 19, type I
|
1.825
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
1.82
|
|
SNAI1
|
snail family zinc finger 1
|
1.807
|
|
KRT18
|
keratin 18, type I
|
1.807
|
|
PHF1
|
PHD finger protein 1
|
1.806
|
|
KRT14
|
keratin 14, type I
|
1.805
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
1.798
|
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1
|
1.794
|
|
CHGA
|
chromogranin A
|
1.793
|
|
RAD51C
|
RAD51 paralog C
|
1.782
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.778
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
1.777
|
|
CD68
|
CD68 molecule
|
1.772
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.768
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.766
|
|
NF1
|
neurofibromin 1
|
1.756
|
|
SNAI2
|
snail family zinc finger 2
|
1.753
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
1.748
|
|
RAD51D
|
RAD51 paralog D
|
1.726
|
|
SATB2
|
SATB homeobox 2
|
1.721
|
|
FOXL2
|
forkhead box L2
|
1.715
|
|
HNF1B
|
HNF1 homeobox B
|
1.713
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
1.711
|
|
MUC1
|
mucin 1, cell surface associated
|
1.687
|
|
ATM
|
ATM serine/threonine kinase
|
1.683
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
1.682
|
|
NCOA2
|
nuclear receptor coactivator 2
|
1.678
|
|
AR
|
androgen receptor
|
1.673
|
|
TP63
|
tumor protein p63
|
1.671
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
1.669
|
|
EWSR1
|
EWS RNA-binding protein 1
|
1.668
|
|
VIM
|
vimentin
|
1.662
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
1.66
|
|
PALB2
|
partner and localizer of BRCA2
|
1.659
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
1.653
|
|
PXDNL
|
peroxidasin-like
|
1.645
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
1.645
|
|
PXDN
|
peroxidasin
|
1.643
|
|
TERT
|
telomerase reverse transcriptase
|
1.636
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.629
|
|
MED12
|
mediator complex subunit 12
|
1.621
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
1.617
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
1.611
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
1.603
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
1.595
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
1.594
|
|
SPOP
|
speckle-type POZ protein
|
1.591
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.591
|
|
STK11
|
serine/threonine kinase 11
|
1.589
|
|
KDR
|
kinase insert domain receptor
|
1.588
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
1.587
|
|
CD8A
|
CD8a molecule
|
1.587
|
|
INSM1
|
insulinoma-associated 1
|
1.577
|
|
CSMD3
|
CUB and Sushi multiple domains 3
|
1.575
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.563
|
|
EGF
|
epidermal growth factor
|
1.555
|
|
GPC3
|
glypican 3
|
1.553
|
|
NDC80
|
NDC80 kinetochore complex component
|
1.546
|
|
RET
|
ret proto-oncogene
|
1.544
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
1.544
|
|
MSLN
|
mesothelin
|
1.538
|
|
BARD1
|
BRCA1 associated RING domain 1
|
1.53
|
|
PAX2
|
paired box 2
|
1.524
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
1.515
|
|
FOLR1
|
folate receptor 1 (adult)
|
1.514
|
|
ALB
|
albumin
|
1.505
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.504
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
1.499
|
|
OVGP1
|
oviductal glycoprotein 1, 120kDa
|
1.497
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
1.497
|
|
CHEK2
|
checkpoint kinase 2
|
1.493
|
|
PDCD1
|
programmed cell death 1
|
1.493
|
|
CHD4
|
chromodomain helicase DNA binding protein 4
|
1.482
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
1.48
|
|
BAZ1A
|
bromodomain adjacent to zinc finger domain, 1A
|
1.477
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
1.476
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.454
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
1.446
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
1.444
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
1.442
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.438
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
1.437
|
|
MUC16
|
mucin 16, cell surface associated
|
1.436
|
|
H2BC21
|
H2B clustered histone 21
|
1.431
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
1.421
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
1.415
|
|
BCORL1
|
BCL6 corepressor-like 1
|
1.408
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
1.405
|
|
TBCE
|
tubulin folding cofactor E
|
1.405
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
1.4
|
|
PCNA
|
proliferating cell nuclear antigen
|
1.398
|
|
H2AC20
|
H2A clustered histone 20
|
1.389
|
|
NCOA1
|
nuclear receptor coactivator 1
|
1.388
|
|
H2AC18
|
H2A clustered histone 18
|
1.388
|
|
RAD51
|
RAD51 recombinase
|
1.386
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.383
|
|
MYBL1
|
v-myb avian myeloblastosis viral oncogene homolog-like 1
|
1.383
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
1.379
|
|
CLDN4
|
claudin 4
|
1.374
|
|
FN1
|
fibronectin 1
|
1.363
|
|
IL6
|
interleukin 6
|
1.353
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
1.348
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
1.347
|
|
PDPN
|
podoplanin
|
1.347
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
1.345
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
1.343
|
|
CDK12
|
cyclin-dependent kinase 12
|
1.341
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.338
|
|
TG
|
thyroglobulin
|
1.335
|
|
MMP9
|
matrix metallopeptidase 9
|
1.329
|
|
SMAD4
|
SMAD family member 4
|
1.326
|
|
SSX2B
|
synovial sarcoma, X breakpoint 2B
|
1.322
|
|
PROM1
|
prominin 1
|
1.321
|
|
POLD1
|
polymerase (DNA directed), delta 1, catalytic subunit
|
1.32
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
1.317
|
|
MMP2
|
matrix metallopeptidase 2
|
1.317
|
|
CHEK1
|
checkpoint kinase 1
|
1.315
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
1.313
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.306
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
1.302
|
|
TNF
|
tumor necrosis factor
|
1.301
|
|
NCOA3
|
nuclear receptor coactivator 3
|
1.293
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
1.291
|
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
1.289
|
|
PTCH1
|
patched 1
|
1.285
|
|
AURKA
|
aurora kinase A
|
1.283
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
1.282
|
|
CDC73
|
cell division cycle 73
|
1.28
|
|
ZNF217
|
zinc finger protein 217
|
1.273
|
|
FLT1
|
fms-related tyrosine kinase 1
|
1.273
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.272
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
1.267
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
1.267
|
|
NOTCH1
|
notch 1
|
1.266
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1.264
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
1.262
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
1.261
|
|
ACTB
|
actin, beta
|
1.26
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
1.259
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.255
|
|
GFAP
|
glial fibrillary acidic protein
|
1.254
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
1.248
|
|
RPL22
|
ribosomal protein L22
|
1.244
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.239
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.238
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.237
|
|
NOTCH3
|
notch 3
|
1.232
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
1.231
|
|
SMIM20
|
small integral membrane protein 20
|
1.226
|
|
NUTM2B
|
NUT family member 2B
|
1.224
|
|
CD4
|
CD4 molecule
|
1.219
|
|
PTHLH
|
parathyroid hormone-like hormone
|
1.217
|
|
WDR38
|
WD repeat domain 38
|
1.213
|
|
INS
|
insulin
|
1.209
|
|
KLK3
|
kallikrein-related peptidase 3
|
1.209
|
|
BRD8
|
bromodomain containing 8
|
1.208
|
|
BAX
|
BCL2-associated X protein
|
1.205
|
|
REEP5
|
receptor accessory protein 5
|
1.203
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
1.199
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
1.197
|
|
PIP
|
prolactin-induced protein
|
1.197
|
|
IGF2
|
insulin-like growth factor 2
|
1.192
|
|
S100A4
|
S100 calcium binding protein A4
|
1.191
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
1.189
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
1.187
|
|
DYNC1I2
|
dynein, cytoplasmic 1, intermediate chain 2
|
1.182
|
|
KRT17
|
keratin 17, type I
|
1.179
|
|
CD24
|
CD24 molecule
|
1.173
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
1.172
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.171
|
|
POU5F1
|
POU class 5 homeobox 1
|
1.169
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.166
|
|
FOXM1
|
forkhead box M1
|
1.161
|
|
MSH3
|
mutS homolog 3
|
1.158
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
1.157
|
|
RB1
|
retinoblastoma 1
|
1.154
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
1.153
|
|
MRE11
|
MRE11 homolog, double strand break repair nuclease
|
1.146
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
1.142
|
|
MEAF6
|
MYST/Esa1-associated factor 6
|
1.139
|
|
GLI1
|
GLI family zinc finger 1
|
1.139
|
|
LAMB4
|
laminin, beta 4
|
1.138
|
|
FLT4
|
fms-related tyrosine kinase 4
|
1.133
|
|
CDK2
|
cyclin-dependent kinase 2
|
1.126
|
|
FANCA
|
Fanconi anemia, complementation group A
|
1.125
|
|
MRPL19
|
mitochondrial ribosomal protein L19
|
1.125
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.124
|
|
FOXO1
|
forkhead box O1
|
1.122
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
1.121
|
|
XAGE2
|
X antigen family, member 2
|
1.117
|
|
IFNG
|
interferon, gamma
|
1.117
|
|
RAD51B
|
RAD51 paralog B
|
1.116
|
|
VCAN
|
versican
|
1.107
|
|
CDH4
|
cadherin 4, type 1, R-cadherin (retinal)
|
1.106
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
1.103
|
|
CTAG1B
|
cancer/testis antigen 1B
|
1.103
|
|
TSC2
|
tuberous sclerosis 2
|
1.102
|
|
HMGA1
|
high mobility group AT-hook 1
|
1.102
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
1.098
|
|
ESS2
|
ess-2 splicing factor homolog
|
1.095
|
|
MAGEA4
|
melanoma antigen family A4
|
1.095
|
|
COMMD3-BMI1
|
COMMD3-BMI1 readthrough
|
1.094
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
1.088
|
|
MUTYH
|
mutY homolog
|
1.088
|
|
CLDN3
|
claudin 3
|
1.087
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
1.086
|
|
SETD2
|
SET domain containing 2
|
1.086
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
1.085
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
1.085
|
|
CREBBP
|
CREB binding protein
|
1.083
|
|
FSCN1
|
fascin actin-bundling protein 1
|
1.079
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
1.075
|
|
S100A6
|
S100 calcium binding protein A6
|
1.075
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
1.071
|
|
CDK6
|
cyclin-dependent kinase 6
|
1.069
|
|
ATR
|
ATR serine/threonine kinase
|
1.062
|
|
MLH3
|
mutL homolog 3
|
1.061
|
|
GNAS
|
GNAS complex locus
|
1.061
|
|
H3-3B
|
H3.3 histone B
|
1.061
|
|
H3C12
|
H3 clustered histone 12
|
1.059
|
|
EZHIP
|
EZH inhibitory protein
|
1.057
|
|
R3HCC1
|
R3H domain and coiled-coil containing 1
|
1.056
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
1.053
|
|
ETV6
|
ets variant 6
|
1.052
|
|
PMS1
|
PMS1 postmeiotic segregation increased 1 (S. cerevisiae)
|
1.047
|
|
MDM4
|
MDM4, p53 regulator
|
1.046
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.043
|
|
H3-5
|
H3.5 histone
|
1.042
|
|
TCHP
|
trichoplein, keratin filament binding
|
1.038
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
1.035
|
|
SMAP1
|
small ArfGAP 1
|
1.035
|
|
FAT3
|
FAT atypical cadherin 3
|
1.034
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
1.034
|
|
ESRRB
|
estrogen-related receptor beta
|
1.033
|
|
IL2
|
interleukin 2
|
1.032
|
|
RSF1
|
remodeling and spacing factor 1
|
1.032
|
|
NKX3-1
|
NK3 homeobox 1
|
1.032
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
1.031
|
|
FOXP3
|
forkhead box P3
|
1.029
|
|
FGF3
|
fibroblast growth factor 3
|
1.028
|
|
BCL2L1
|
BCL2-like 1
|
1.025
|
|
SCGB2A1
|
secretoglobin, family 2A, member 1
|
1.025
|
|
H3-4
|
H3.4 histone, cluster member
|
1.022
|
|
PTPA
|
protein phosphatase 2 phosphatase activator
|
1.018
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
1.018
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.018
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
1.017
|
|
H3C13
|
H3 clustered histone 13
|
1.012
|
|
CD163
|
CD163 molecule
|
1.007
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
1.005
|
|
JAK2
|
Janus kinase 2
|
1.005
|
|
CLDN7
|
claudin 7
|
1.005
|
|
FGF7
|
fibroblast growth factor 7
|
1.003
|
|
IL1B
|
interleukin 1, beta
|
1.002
|
